Qsam Biosciences Stock Working Capital
| QSAMDelisted Stock | USD 4.49 0.05 1.13% |
Qsam Biosciences fundamentals help investors to digest information that contributes to Qsam Biosciences' financial success or failures. It also enables traders to predict the movement of Qsam OTC Stock. The fundamental analysis module provides a way to measure Qsam Biosciences' intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Qsam Biosciences otc stock.
Qsam |
Qsam Biosciences OTC Stock Working Capital Analysis
Qsam Biosciences' Working Capital is a measure of company efficiency and operating liquidity. The working capital is usually calculated by subtracting Current Liabilities from Current Assets. It is an important indicator of the firm ability to continue its normal operations without additional debt obligations. .
More About Working Capital | All Equity Analysis
Working Capital | = | Current Assets | - | Current Liabilities |
Current Qsam Biosciences Working Capital | 672.35 K |
Most of Qsam Biosciences' fundamental indicators, such as Working Capital, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Qsam Biosciences is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Working Capital can be positive or negative, depending on how much of current debt the company is carrying on its balance sheet. In general terms, companies that have a lot of working capital will experience more growth in the near future since they can expand and improve their operations using existing resources. On the other hand, companies with small or negative working capital may lack the funds necessary for growth or future operation. Working Capital also shows if the company has sufficient liquid resources to satisfy short-term liabilities and operational expenses.
CompetitionBased on the company's disclosures, Qsam Biosciences has a Working Capital of 672.35 K. This is 99.84% lower than that of the Biotechnology sector and 99.88% lower than that of the Health Care industry. The working capital for all United States stocks is 99.95% higher than that of the company.
Qsam Working Capital Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Qsam Biosciences' direct or indirect competition against its Working Capital to detect undervalued stocks with similar characteristics or determine the otc stocks which would be a good addition to a portfolio. Peer analysis of Qsam Biosciences could also be used in its relative valuation, which is a method of valuing Qsam Biosciences by comparing valuation metrics of similar companies.Qsam Biosciences is currently under evaluation in working capital category among its peers.
Qsam Fundamentals
| Return On Equity | -33.77 | |||
| Return On Asset | -2.38 | |||
| Current Valuation | 36.03 M | |||
| Shares Outstanding | 4.45 M | |||
| Shares Owned By Insiders | 52.36 % | |||
| Price To Book | 201.64 X | |||
| Price To Sales | 1.71 X | |||
| Gross Profit | 916.67 K | |||
| EBITDA | (3.94 M) | |||
| Net Income | (4.39 M) | |||
| Cash And Equivalents | 429.35 K | |||
| Cash Per Share | 0.25 X | |||
| Total Debt | 7.5 K | |||
| Debt To Equity | 2.08 % | |||
| Current Ratio | 0.23 X | |||
| Book Value Per Share | 0.04 X | |||
| Cash Flow From Operations | (2.85 M) | |||
| Earnings Per Share | (1.69) X | |||
| Beta | 1.81 | |||
| Market Capitalization | 73.79 B | |||
| Total Asset | 1.71 M | |||
| Retained Earnings | (40.16 M) | |||
| Working Capital | 672.35 K | |||
| Net Asset | 1.71 M |
About Qsam Biosciences Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Qsam Biosciences's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Qsam Biosciences using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Qsam Biosciences based on its fundamental data. In general, a quantitative approach, as applied to this otc stock, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Building efficient market-beating portfolios requires time, education, and a lot of computing power!
The Portfolio Architect is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.
Try AI Portfolio ArchitectCheck out Your Equity Center to better understand how to build diversified portfolios. Also, note that the market value of any otc stock could be closely tied with the direction of predictive economic indicators such as signals in nation. Note that the Qsam Biosciences information on this page should be used as a complementary analysis to other Qsam Biosciences' statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Investing Opportunities module to build portfolios using our predefined set of ideas and optimize them against your investing preferences.
Other Consideration for investing in Qsam OTC Stock
If you are still planning to invest in Qsam Biosciences check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Qsam Biosciences' history and understand the potential risks before investing.
| Financial Widgets Easily integrated Macroaxis content with over 30 different plug-and-play financial widgets | |
| Price Ceiling Movement Calculate and plot Price Ceiling Movement for different equity instruments | |
| Stock Screener Find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook. | |
| Price Exposure Probability Analyze equity upside and downside potential for a given time horizon across multiple markets | |
| Insider Screener Find insiders across different sectors to evaluate their impact on performance | |
| Analyst Advice Analyst recommendations and target price estimates broken down by several categories | |
| AI Portfolio Architect Use AI to generate optimal portfolios and find profitable investment opportunities | |
| Alpha Finder Use alpha and beta coefficients to find investment opportunities after accounting for the risk | |
| USA ETFs Find actively traded Exchange Traded Funds (ETF) in USA |